WTAP‐mediated m6A modification of circSMOC1 promotes the tumorigenesis and invasion of NSCLC cells by regulating the miR‐612/CCL28 axis, offering a potential therapeutic biomarker for NSCLC. The gene discussed is WTAP; the disease is non-small cell lung carcinoma.